These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Downregulation of reversion-inducing cysteine-rich protein with Kazal motifs in malignant melanoma: inverse correlation with membrane-type 1-matrix metalloproteinase and tissue inhibitor of metalloproteinase 2. Jacomasso T, Trombetta-Lima M, Sogayar MC, Winnischofer SM. Melanoma Res; 2014 Feb; 24(1):32-9. PubMed ID: 24335752 [Abstract] [Full Text] [Related]
4. A Disintegrin and Metalloproteinase Domain 17 Regulates Colorectal Cancer Stem Cells and Chemosensitivity Via Notch1 Signaling. Wang R, Ye X, Bhattacharya R, Boulbes DR, Fan F, Xia L, Ellis LM. Stem Cells Transl Med; 2016 Mar; 5(3):331-8. PubMed ID: 26744411 [Abstract] [Full Text] [Related]
5. The tumor suppressor RECK interferes with HER-2/Neu dimerization and attenuates its oncogenic signaling. Hong KJ, Hsu MC, Hou MF, Hung WC. FEBS Lett; 2011 Feb 18; 585(4):591-5. PubMed ID: 21255571 [Abstract] [Full Text] [Related]
12. RECK expression in osteosarcoma: correlation with matrix metalloproteinases activation and tumor invasiveness. Kang HG, Kim HS, Kim KJ, Oh JH, Lee MR, Seol SM, Han I. J Orthop Res; 2007 May 18; 25(5):696-702. PubMed ID: 17262820 [Abstract] [Full Text] [Related]
14. Reversion-inducing cysteine-rich protein with Kazal motif (RECK) expression: an independent prognostic marker of survival in colorectal cancer. Stenzinger A, von Winterfeld M, Rabien A, Warth A, Kamphues C, Dietel M, Weichert W, Klauschen F, Wittschieber D. Hum Pathol; 2012 Aug 18; 43(8):1314-21. PubMed ID: 22397871 [Abstract] [Full Text] [Related]
15. A Hypothesis for the Role of RECK in Angiogenesis. Gutiérrez J, Droppelmann CA, Salsoso R, Westermeier F, Toledo F, Salomon C, Sanhueza C, Pardo F, Leiva A, Sobrevia L. Curr Vasc Pharmacol; 2016 Aug 18; 14(1):106-15. PubMed ID: 26463982 [Abstract] [Full Text] [Related]